August is normally quiet in Washington, DC, but in keeping with the theme of 2020, this month has been more frenetic. While we beat back new taxes on the insights industry, the Insights Association has had to tangle with the demise of the U.S.-EU Privacy Shield for data transfer, further pandemic relief, some new threats to pharma MR, the finalization of CCPA, and an attempt to rush the 2020 Census that threatens the statistical viability of most marketing research and data analytics in the U.S.
A look back, counting down the Insights Association's top seven advocacy wins from the last decade that helped our marketing research and data analytics industry members create competitive advantage.
In Alaska, Rep.
Recent wins for pharmaceutical marketing research in Maine and DC leave only West Virginia and Vermont as the jurisdictions currently restricting or prohibiting research with physicians and healthc